Trials / Completed
CompletedNCT00635934
A-MAV™ Anterior Motion Segment Replacement
A Prospective, Non-Randomized Pilot Clinical Investigation of the A-MAV™ Anterior Motion Segment Replacement in Patients With Lumbar Degenerative Disc Disease
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 53 (actual)
- Sponsor
- Medtronic Spinal and Biologics · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this clinical trial is to collect safety and effectiveness data concerning the A-MAV™ Anterior Motion Segment Replacement device as a method of treating patients with lumbar degenerative disc disease at one level from L4-S1. Overall success will be the primary clinical endpoint.
Detailed description
For this clinical trial, there is only one treatment group- patients receiving the A-MAV™ Anterior Motion Segment Replacement via an anterior surgical approach in the lumbar region of the spine from L4-S1.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | A-MAV™ disc | The A-MAV™ device is a spinal arthroplasy system intended to replace a damaged spinal disc. It is inserted using an anterior surgical approach and aims to reduce low back pain and maintain disc height at the affected level. |
Timeline
- Start date
- 2005-12-01
- Primary completion
- 2009-10-01
- Completion
- 2010-05-01
- First posted
- 2008-03-14
- Last updated
- 2018-09-18
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00635934. Inclusion in this directory is not an endorsement.